Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)
BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various customers in the chemical market primarily in the United States and Canada. The company is headquartered in Montreal, Canada.
52W High
$26.62
52W Low
$2.88
MA Status:
50D: Above
200D: Below
Beta (~1 neutral, <0.9 lower risk)
N/A
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
N/A
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
44.17
P/B (<3 favorable)
0.58
Ownership
BalancedSource: Overview
Insiders (1–5% typical)
3.63%
Institutions (25–75% balanced)
67.97%
Shares Outstanding
35,850,000
Float
24,308,800
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
3,863,000
Gross Profit (TTM)
-7,298,000
EPS (TTM)
-6.81
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-10.27%
ROE (TTM) (>15% strong)
-0.36%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentumValue
0.1247
Previous
0.1378
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025